1,687
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Amelioration of hyperglycaemia and modulation of antioxidant status by Alcea rosea seeds in alloxan-induced diabetic rats

, , , &
Pages 1849-1855 | Received 28 Jul 2016, Accepted 03 May 2017, Published online: 01 Jun 2017

References

  • Aggarwal A, Singla SK, Tandon C. 2014. Urolithiasis: phytotherapy as an adjunct therapy. Indian J Exp Biol. 52:103–111.
  • Ahmadi M, Rad A, Rajaei Z, Hadjzadeh M, Mohammadian N, Tabasi N. 2012. Alcea rosea root extract as a preventive and curative agent in ethylene glycol-induced urolithiasis in rats. Indian J Pharmacol. 44:304–307.
  • Ahmed I, Roy BC, Subramaniam D, Ganie SA, Kwatra D, Dixon D, Anant S, Zargar MA, Umar S. 2016. An ornamental plant targets epigenetic signaling to block cancer stem cell-driven colon carcinogenesis. Carcinogenesis. 37:385–396.
  • American Diabetes Association (ADA). 2014. Diagnosis and classification of diabetes mellitus. Diabetes Care. 37:81–90.
  • Beauchamp C, Fridovich I. 1971. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem. 44:276–287.
  • Belkina LM, Smirnova EA, Terekhina OL, Kruglov SV, Boichuk ES. 2013. Role of nitric oxide in the pathogenesis of alloxan diabetes. Bull Exp Biol Med. 154:602–605.
  • Bloomgarden ZT. 1997. Antioxidants and diabetes. Diabetes Care. 20:670.
  • Claiborne AL. 1985. Catalase activity. CRC handbook of methods for oxygen radical research, vol. 1. Boca Raton: CRC Press; p. 283–284.
  • Davidson MB. 1991. Diabetes mellitus: diagnosis and treatment. New York: Churchill Livingstone Incorporated USA.
  • Eurich DT, McAlister FA, Blackburn DF, Majumdar SR, Tsuyuki RT, Varney J, Johnson JA. 2007. Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review. BMJ. 335:497.
  • Haque R, Bin-Hafeez B, Parvez S, Pandey S, Sayeed I, Ali M, Raisuddin S. 2003. Aqueous extract of walnut (Juglans regia L.) protects mice against cyclophosphamide-induced biochemical toxicity. Hum Exp Toxicol. 22:473–480.
  • Heikkila RE, Winston B, Cohen G, Barden H. 1976. Alloxan-induced diabetes-evidence for hydroxyl radical as a cytotoxic intermediate. Biochem Pharmacol. 25:1085–1092.
  • Hussain L, Akash M, Tahir M, Rehman K, Ahmed K. 2014. Hepatoprotective effects of methanolic extract of Alcea rosea against acetaminophen-induced hepatotoxicity in mice. Bangladesh J Pharmacol. 9:322–327.
  • Jemai H, El Feki A, Sayadi S. 2009. Antidiabetic and antioxidant effects of hydroxytyrosol and oleuropein from olive leaves in alloxan-diabetic rats. J Agric Food Chem. 57:8798–8804.
  • Jouad H, Rhiouani H, El-Hilaly J, Eddouks M. 2001. Ethnobotanical survey of medicinal plants used for the treatment of diabetes, cardiac and renal diseases in the north center region of Morocco (Fez-Boulemane). J Ethnopharmacol. 77:175–182.
  • Lenzen S. 2008. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 51:216–226.
  • Li WL, Zheng HC, Bukuru J, De Kimpeb N. 2004. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol. 92:1–21.
  • Lim TK. 2014. Edible medicinal and non medicinal plants, vol. 8. Dordrecht, Heidelberg, New Work, London: Springer; p. 292–299.
  • Malviya N, Jain S, Malviya S. 2010. Antidiabetic potential of medicinal plants. Acta Pol Pharm. 67:113–118.
  • Modak M, Dixit P, Londhe J, Ghaskadbi S, Devasagayam TPA. 2007. Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr. 40:163.
  • Moron MS, Depierre JW, Mannervik B. 1979. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta. 582:67–78.
  • Mule VS, Naikwade NS, Magdum CS, Jagtap VA. 2016. Antidiabetic activity of extracts of Pithecellobium dulce Benth leaves in alloxan induced diabetic rats. Int J Pharm Sci Drug Res. 8:275–280.
  • Negres S, Chirita C, Morosan E, Arsene AL. 2003. Experimental pharmacological model of diabetes induction with alloxan in rat. Farmacia. 61:313–322.
  • Niehaus WG, Samuelson B. 1968. Formation of malondialdehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem. 6:126–130.
  • Packer L, Weber SU, Rimbach G. 2001. Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling. J Nutr. 131:369S–373S.
  • Pareek H, Sharma S, Khajja BS, Jain K, Jain GC. 2009. Evaluation of hypoglycemic and anti-hyperglycemic potential of Tridax procumbens (Linn.). BMC Complement Altern Med. 9:1.
  • Pavana P, Sethupathy S, Manoharan S. 2007. Antihyperglycemic and antilipidperoxidative effects of Tephrosia purpurea seed extract in streptozotocin induced diabetic rats. Indian J Clin Biochem. 22:77–83.
  • Rice EC, Miller N, Paganga G. 1997. Antioxidant properties of phenolic compounds. Trends Plant Sci. 2:152–159.
  • Rice EC, Miller NJ, Paganga G. 1996. Structure–antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med. 20:933–956.
  • Rodbard H, Blonde L, Braithwaite S, Brett E, Cobin R, Handelsman Y, Hellman R, Jellinger P, Jovanovic L, Levy P. 2007. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract. 13:1–68.
  • Rolo AP, Palmeira CM. 2006. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol. 212:167–178.
  • Sharma N, Trikha P, Athar M, Raisuddin S. 2000. Inhibitory effect of Emblica officinalis on the in vivo clastogenicity of benzo[a]pyrene and cyclophosphamide in mice. Hum Exp Toxicol. 19:377–384.
  • Singleton VL, Orthofer R, Lamuela-Raventós RM. 1999. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin–Ciocalteu reagent. Methods Enzymol. 299:152–178.
  • Wang DF, Shang JY, Yu QH. 1989. Analgesic and anti-inflammatory effects of the flower of Althaea rosea (L.) Cav. Zhongguo Zhong Yao Za Zhi. 14:46–48.
  • Whiting D, Guariguata L, Weil C, Shawj J. 2011. IDF Diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 94:311–321.
  • Wild S, Roglic G, Green A, Sicree R, King H. 2004. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 27:1047–1053.